In:
Saudi Journal of Pathology and Microbiology, SASPR Edu International Pvt. Ltd, Vol. 7, No. 12 ( 2022-12-15), p. 457-462
Abstract:
The most typical primary liver tumour, hepatocellular carcinoma, is becoming more prevalent. The two-gold standard curative treatment options are transplantation and surgical resection, but fewer than 20% of patients qualify as surgical candidates due to severe liver disease and/or co-morbidities. For the treatment of HCC that is inoperable, numerous interventional radiological techniques have been developed and thoroughly researched. The treatment of HCC currently heavily relies on interventional radiology. These methods have considerably aided in halting disease development in liver transplant candidates and extending survival in non-candidates. These medicines stand out for their low toxicity profiles, potent tumour response, and preservation of healthy hepatic parenchyma.
Type of Medium:
Online Resource
ISSN:
2518-3362
,
2518-3370
DOI:
10.36348/sjpm.2022.v07i12.002
Language:
Unknown
Publisher:
SASPR Edu International Pvt. Ltd
Publication Date:
2022
Permalink